77.80 USD
▲-0.69+1.95%
盘后 76.31 0.00%
2026-08-03
市值
$2.99B
市盈率
—
EPS
-6.56
股息率
—
52 周区间
40.00 – 99.50
成交量
380.03K
Beta
2.07
目标价
101.00
52W 低 40.0052W 高 99.50
价格走势
公司简介
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the tre...